Szukamy dostawców (hurtownie, importerzy, producenci):
- zeszyty gładkie – 60 kartek w partiach po 1000 sztuk [1K],
- zeszyty w kratkę – 60 kartek w partiach po 1000 sztuk [1K],
- zeszyty w linie – 60 kartek w partiach po 1000 sztuk [1K],
- bloki rysunkowe – w partiach po 1000 sztuk [1K],
- kolorowanki dla dzieci – w partiach po 1000 sztuk [1K],.
Chętnie stała współpraca..
Prosimy o kontakt zainteresowanych..
Hi friends, nice post and good urging commented here, I am in fact enjoying by these.
I offer you entry to my materials, books, readings, songs, video-lessons, all supplies in your course, all adapted to your stage.
LONDON, Sept 28 (Reuters) – Philip Morris International (PMI) on Thursday signalled a slower than anticipated U.S.
roll out of its IQOS heated tobacco device, a choice analysts said
was positive for its competitors in the short term.
The New York-listed Marlboro maker also said it aims for more than two thirds of its net revenues to come
from „smoke-free” products by 2030, up from 50% in 2025, as it tries to transform its image from a
cigarette purveyor to a driver of the shift to healthier alternatives.
Investors have been closely watching IQOS’ entry into the U.S., the world’s largest market for nicotine products, and had
been expecting it from May 2024 next year. Reuters reported on Wednesday that
PMI is hiring lobbyists across a host of key U.S.
states ahead of the launch.
Chief Executive Jacek Olczak said IQOS would launch in four cities in two unnamed U.S.
states from 2024, but a national launch would only come after PMI receives approval to sell
the latest version, known as IQOS ILUMA.
The company was planning to apply for approval in October and expected it from 2025, he continued.
„We need to warm up the tyres,” he said of the initial launch, which would help PMI fine tune its approach.
A national roll-out of ILUMA would follow but in phases, he continued,
adding launching in 10 states in the first year would make sense.
Meaningful traction for PMI’s heated tobacco products in the U.S.
„now looks delayed until ILUMA,” Owen Bennett,
equity analyst at Jefferies, said in a note, adding this was a positive for
PMI’s rivals.
Olczak also signalled that PMI’s push into non-nicotine products was no
longer a priority. It recently scrapped an ambition for $1 billion in net
revenues to come from sales of such products by 2025.
Instead, PMI will focus its resources on IQOS and nicotine
pouch brand ZYN, Olczak said, adding it had been too optimistic around acceptance of big tobacco companies
operating outside of nicotine.
PMI also announced updated medium-term targets including for revenue and earnings per share, and ambitious volume targets for
IQOS and ZYN.
ZYN and other oral nicotine products in the U.S. would help drive an expected $2 billion in revenues there in 2024, even before IQOS ILUMA, executives said.
PMI shares were up 1.5% on Thursday. (Reporting by Emma Rumney in London and Granth Vanaik in Bengaluru; additional
reporting by Ananya Mariam Rajesh in Bengaluru; Writing by Emma Rumney; Editing by Elaine Hardcastle and Josie Kao)
By Toni Clarke
WASHINGTON, Jan 25 (Reuters) – Philip Morris International Inc should
not be allowed to claim its iQOS electronic tobacco product is less risky than cigarettes,
U.S. health advisers said on Thursday, dealing a blow
to the company as it seeks to strengthen its portfolio of alternative nicotine devices.
The recommendation is not binding and the U.S.
Food and Drug Administration could still allow Philip Morris to
make such a claim, but some analysts think the agency might ask for additional data
first.
„It’s a process,” said Bonnie Herzog, an analyst at Wells Fargo.
The FDA will likely approve the request eventually, she said, „but timing is tough to predict.”
Philip Morris, which has spent more than $3 billion to develop products
that can counteract the decline in traditional cigarette sales, said it was encouraged by some of the committee members’ comments that iQOS may have risk-reduction potential.
„We are confident in our ability to address the valid questions raised by the Committee with the FDA as the review process for our application continues,”
Corey Henry, a Philip Morris spokesman, said in a statement.
FDA Commissioner Scott Gottlieb recently proposed a broad tobacco policy
shift that would reduce nicotine in cigarettes to „non-addictive” levels while increasing
development of lower-risk alternatives for those unable to quit.
IQOS is a sleek, penlike device that heats tobacco but does not ignite it – an approach Philip Morris says produces far lower levels of carcinogens than regular cigarettes.
It is used by nearly 4 million people in 30 markets outside the United States but needs FDA authorization to be marketed
in America.
Last month, a Reuters investigation described irregularities in the clinical trials that supported Philip Morris’ iQOS application to the FDA.
website and website
The company’s shares fell 2.8 percent to close at $107.49 on Thursday, after falling as
much as 6.8 percent.
Matthew Myers, president of the Campaign for Tobacco Free Kids, said panelists „identified that serious questions remain” about the company’s
application. He said it could amend the application and the panel’s recommendation does
not rule out an ultimate approval.
The panel said Philip Morris had not proven that iQOS reduced harm compared
with cigarettes. It did conclude that the product exposes users to lower levels of harmful chemicals but said
the company had not shown that lowering exposure to those chemicals is reasonably likely to translate into a
measurable reduction in disease or death.
Philip Morris needs to show both in order to claim in its marketing materials that the
product reduces a user’s exposure to harmful chemicals.
Some panelists were concerned that not all the harmful or potentially harmful chemicals in iQOS were
lower than in cigarettes. Philip Morris presented data showing an overall exposure reduction of about 95 percent.
„The negative recommendations did not come as a surprise,” said Gregory Conley, president of the American Vaping Association. He
said the panelists „disconnected themselves from the facts in favor of ideology.”
The FDA is expected to decide whether Philip Morris can sell iQOS within the next few
months. It will decide separately whether to authorize the modified-risk claims.
There is no time frame for when that decision might come.
If cleared, iQOS would be sold in the United States by Philip
Morris’ partner Altria Group Inc. Altria shares closed 2.3 percent lower at $69.91.
(Reporting by Toni Clarke in Washington; Editing
by Susan Thomas and Matthew Lewis)
I have noticed that fees for internet degree professionals tend to be a fantastic value. For instance a full Bachelor’s Degree in Communication in the University of Phoenix Online consists of Sixty credits at $515/credit or $30,900. Also American Intercontinental University Online offers a Bachelors of Business Administration with a whole school feature of 180 units and a worth of $30,560. Online learning has made obtaining your college diploma so much easier because you could earn your current degree through the comfort of your home and when you finish working. Thanks for all tips I have really learned from your web-site.
As a field person, one will get driving instructions to the consumer location.
This is a topic that’s close to my heart… Take care!
Where are your contact details though?
He was a retired farmer and a member of the Luther First Christian Church.
I was wondering if you ever thought of changing the structure
of your website? Its very well written; I love
what youve got to say. But maybe you could a little more in the way of content so people could connect with it better.
Youve got an awful lot of text for only having one or two images.
Maybe you could space it out better?
Way cool! Some very valid points! I appreciate you penning this article and also the rest of the site is really good.
I’m curious to find out what blog system you have been using?
I’m having some small security issues with my latest blog and I’d like to find something more safeguarded.
Do you have any suggestions?
It’s very easy to find out any topic on web as compared to books, as I found this article at this web
site.
Unlock Special Savings at Shop My Exchange.
For military personnel and veterans, discovering new savings on daily essentials is always
a great benefit. That’s where shopmyexchange plays a key role—a tailored shopping platform focused on the military community.
From active-duty service members to retired
military, AAFES provides incredible perks, making it a top choice for
value and accessibility.
Tax-Free Shopping That Save You More
One of the standout features of Shop My Exchange is its tax-free shopping experience.
Unlike traditional stores, orders made through
the platform are completely tax-free, guaranteeing
that every dollar you spend stretches further.
Whether you’re shopping for tech products, home goods, fashion, or everyday essentials, this unique
offer adds up to huge discounts over time.
If you are going for best contents like myself, only pay a visit this web
page all the time as it offers feature contents, thanks
Hi, this weekend is pleasant in support of me, since this
moment i am reading this enormous informative article here
at my home.
It’s remarkable in favor of me to have a web page, which is
useful in favor of my know-how. thanks admin
An impressive share! I have just forwarded this onto a coworker who
had been doing a little homework on this. And he in fact bought
me dinner due to the fact that I discovered it for him…
lol. So allow me to reword this…. Thank YOU for the meal!!
But yeah, thanks for spending the time to talk about this issue here on your site.
Wow that was strange. I just wrote an extremely long comment
but after I clicked submit my comment didn’t appear. Grrrr…
well I’m not writing all that over again. Anyhow, just wanted to say excellent
blog!
This is a topic that is near to my heart… Best
wishes! Exactly where are your contact details though?
I do consider all of the ideas you have presented in your post.
They’re really convincing and can certainly work.
Still, the posts are very brief for starters. May just you please prolong them a bit from subsequent time?
Thank you for the post.